Insights and expectations of healthcare professionals on the implementation of the updated pediatric regional immunization Calendar in Calabria, Italy

Hum Vaccin Immunother. 2023 Dec 15;19(3):2275475. doi: 10.1080/21645515.2023.2275475. Epub 2023 Oct 30.

Abstract

The Regional Immunization Calendar in Calabria, a region of Italy, was updated in 2022, introducing optional co-administration of three injectable vaccines, with one oral vaccine, at 3 and 5 months old, and three injectable vaccines at 13-14 months old. In this project, the opinions and expectations of healthcare professionals (HCPs) in Calabria were investigated, with respect to the updated recommended practices. An 11-question survey was developed, which addressed concepts and topics related to immunization calendar implementation. Focus group discussions were also organized to provide further insight on the survey findings. A total of 132 HCPs completed the survey (86 public health providers [PHs] and 46 family pediatricians [FPs]). Overall, ≥50% of respondents agreed that vaccine co-administration would be advantageous for public health by reducing the number of vaccination sessions required. Most PHs and FPs agreed that dissemination of available safety data on vaccine co-administration is a necessary action to facilitate effective implementation of the strategy into clinical practice. The importance of safety data related to vaccine co-administration was supported further by discussions held in PH and FP focus groups. Overall, these findings demonstrate support from HCPs in Calabria for vaccine co-administration, and highlight key activities needed for successful uptake.

Keywords: Calabria; Italy; Vaccination; co-administration; healthcare professionals; immunization; national immunization program.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Immunization
  • Infant
  • Italy
  • Motivation*
  • Vaccination
  • Vaccines*

Substances

  • Vaccines

Grants and funding

This project was carried out in collaboration with GlaxoSmithKline Biologicals SA. Support for third-party writing assistance for this article, provided by Samuel Shields, Costello Medical, UK and was funded by GSK in accordance with Good Publication Practice (GPP 2022) guidelines (https://www.ismpp.org/gpp-2022).